Atlas Trials

Efavirenz to Dolutegravir Switch in Patients With CNS Toxicity

Clinical trial NCT02285374 · UNKNOWN

Trial details

NCT number
NCT02285374
Sponsor
St Stephens Aids Trust
Status
UNKNOWN
Phase
Phase 4
Study type
INTERVENTIONAL
HIV
Start date
2014-11-01
Primary completion
2015-03-01
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.